Dataset Information


Undifferentiated pleomorphic sarcoma recapitulates the expressional profile of Subtype II Leiomyosarcoma

ABSTRACT: Background: Undifferentiated pleomorphic sarcoma (UPS), used to be called malignant fibrous histiocytoma (MFH), is a malignant soft tissue tumor of uncertain origin, and is characterized by morphology. UPS often share similar morphological characters with other sarcomas, especially Leiomyosarcoma. Leiomyosarcoma (LMS) is another malignant soft tissue sarcoma with complex genomic abnormalities, origin from smooth muscle. As a result, development of gene signature and/or biomarkers distinguishing UPS and LMS will definitely help the pathologist to precisely diagnose those patients. However, in the past, UPS was reported to be indistinguishable with LMS by genomic profiles. Methods and Results: In this study, 3’ end RNA Sequencing (3SEQ) was used to expression profile 6 UPS and 99 LMS cases. Overall, UPS was undistinguished with LMS by 3SEQ data, however, when we stratified LMS into three subtypes, UPS was shown to share similar expression pattern with Subtype II LMS, but had distinct molecular expression patterns with Subtype I and Subtype III LMS. Additional Immunohistochemistry staining by using LMS Subtype I and Subtype II markers validated that UPSs were positive for Subtype II marker ARL4C, but negative for Subtype I marker LMOD1. Furthermore, CD4 was shown to be significantly more highly expressed in UPS than LMS in both mRNA and protein levels. Conclusion: This study first reported that UPS shared similar gene expression pattern with subtype II LMS and UPS recapitulated the expression profiles of subtype II LMS. In this study, 3’ end RNA Sequencing (3SEQ) was used to expression profile 6 UPS and 99 LMS cases. In order to explore the molecular differences between UPS and LMS, We analyzed the expression data by SAMseq to identify the genes which were significantly differently expressed between UPS and LMS, between UPS and each LMS subtype.

ORGANISM(S): Homo sapiens  

SUBMITTER: Robert B West   Matt van de Rijn  Xiangqian Guo  Shirley X Zhu  Sushama Varma  Shirley Kwok 

PROVIDER: E-GEOD-53844 | ArrayExpress | 2015-05-19



altmetric image


Clinically Relevant Molecular Subtypes in Leiomyosarcoma.

Guo Xiangqian X   Jo Vickie Y VY   Mills Anne M AM   Zhu Shirley X SX   Lee Cheng-Han CH   Espinosa Inigo I   Nucci Marisa R MR   Varma Sushama S   Forgó Erna E   Hastie Trevor T   Anderson Sharon S   Ganjoo Kristen K   Beck Andrew H AH   West Robert B RB   Fletcher Christopher D CD   van de Rijn Matt M  

Clinical cancer research : an official journal of the American Association for Cancer Research 20150420 15

Leiomyosarcoma is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for leiomyosarcoma. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous study on 51 leiomyosarcomas, we identified three molecular subtypes in leiomyosarcoma. The current study was performed to determine whether the existence of these subtypes could be confirmed in independen  ...[more]

Similar Datasets

2015-05-19 | E-GEOD-45510 | ArrayExpress
| GSE45510 | GEO
2015-05-19 | E-GEOD-54511 | ArrayExpress
2009-03-24 | GSE13775 | GEO
2010-10-08 | E-GEOD-13775 | ArrayExpress
| GSE62544 | GEO
| GSE54511 | GEO
2007-04-01 | GSE6481 | GEO
| GSE68304 | GEO
| GSE68295 | GEO